FDA clears Myrava’s patient-specific bolus device

The device is intended to help clinicians control radiation dose delivery and improve positioning during radiotherapy.

Myrava, formerly known as Ricoh 3D for Healthcare, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its patient-specific, 3D-printed bolus device used in radiation therapy.

Known as the Myrava Bolus or 3D Bolus, the accessory is placed directly on a patient’s skin during treatment. It is designed according to the radiation therapist’s plan for the individual patient and the specifications of their treatment.

The device aims to help clinicians control radiation dose delivery and improve positioning during radiotherapy.

Sign up for Blog Updates